News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Alfonso de Egaña, CEO de Molefy Pharma
#NewAseBioMember | “AseBio is a strategic opportunity to connect with the national and international biotechnology ecosystem”
Corporate
Meet Molefy Pharma, our new member. We spoke with Alfonso de Egaña, CEO.
AseBio - MOLEFY PHARMA
EDIFICIO ORYZON
ORYZON reports financial results and corporate update for quarter ended December 31st, 2025
Healthcare · Innovative drugs · Personalized medicine · Advanced therapies · Financing
Strong cash position at year-end 2025: $33.3 million (€28.4 million).
Partners - Oryzon Genomics
Científica observando muestras a través de un microscopio
Sequencing to diagnose earlier: how biotechnology can help short the rare diseases diagnostic odyssey
Healthcare · Rare diseases
In a context in which most of these pathologies have a genetic origin, tools such as whole genome…
Partners - Illumina
Cartel de la sesión de Genomcore en el Mobile World Congress 2026
Made of Genes Presents the "Athlete of the Future" at the Mobile World Congress 2026
Digitalization
The roundtable will address the use of artificial intelligence to integrate biomedical and…
Partners - GENOMCORE
CEO de Natac, Antonio Delgado
Natac to participate in CBE JU Stakeholder Forum
Bioeconomy
The second edition of this high-level event will take place on March 24 in Brussels under the motto…
Partners - Natac Group
Cajas apiladas en un almacén
The new European Regulation on unsold products highlights the role of biotechnology in driving the circular economy across the entire value chain
Industrial biotechnology · Bioeconomy · Circular economy
For the biotechnology sector, it represents both a challenge and an opportunity, as it requires…
Médico
ORYZON receives European Medicines Agency approval to initiate a Phase II study of iadademstat in essential thrombocythemia
Healthcare · Innovative drugs
Essential thrombocythemia is the most common type of myeloproliferative neoplasm (MPN) and is…
Partners - Oryzon Genomics
José María del Valle Escalante, nuevo director de Zona Cataluña y Aragón de PONS IP
José María del Valle Escalante, new Catalonia and Aragon Region Director of PONS IP
Talento
Partners - PONS IP
Logo de BCN Health
BCN HEALTH has published 11 studies in 2025 and 2026 evaluating the incidence, productivity loss, and disease costs in Spain and Europe
Healthcare
These studies have provided new, robust data to assist decision-makers in resource allocation and…
Partners - BCN Health